General Atlantic, a global growth equity firm, has hired Mark Stevenson as a senior adviser.
In his role, Stevenson will provide strategic counsel and support to the firm’s investment teams and portfolio companies in the life sciences sector. Most recently, Stevenson served as executive vice president and chief operating officer at Thermo Fisher Scientific, a company providing life science services, analytical instruments, diagnostics and pharma services. He was responsible for the company’s portfolio of life science, analytical and diagnostic businesses as well as the company’s innovation and digital strategy.
Mark has a strong track record leading public and private companies and driving strategic growth, leveraging his expertise across many areas within life sciences including genomics and enabling tools,” comments Brett Zbar, managing director and global head of life sciences at General Atlantic. “We believe he will bring great value to our portfolio and be an important partner to our life sciences team in seeking to identify emerging and compelling opportunities for investment in what we view as a golden age of biology.”